Skip to main content
Top
Published in: Reproductive Biology and Endocrinology 1/2021

Open Access 01-12-2021 | Infertility | Research

Patients with IVF complicated by moderate-to-critical OHSS experience increased thrombosis, GDM and neonatal NICU admission but slightly shorter gestation compared with matched IVF counterparts: A retrospective Chinese cohort study

Authors: Linli Hu, Rui Xie, Mengying Wang, Yingpu Sun

Published in: Reproductive Biology and Endocrinology | Issue 1/2021

Login to get access

Abstract

Background

Ovarian hyperstimulation syndrome (OHSS) is a common disease during controlled ovarian hyperstimulation treatment. However, the obstetric and neonatal outcomes of this group of patients are unknown. The aim of this study was to explore the effects of late moderate-to-critical OHSS on obstetric and neonatal outcomes.

Methods

This prospective observational study included 17,537 patients who underwent IVF/ICSI-fresh embryo transfer (ET) between June 2012 and July 2016 and met the inclusion criteria, including 7,064 eligible patients diagnosed with clinical pregnancy. Ultimately, 6,356 patients were allocated to the control group, and 385 patients who were hospitalized and treated at the center for late moderate-to-critical OHSS were allocated to the OHSS group. Then, propensity score matching analysis was performed, matching nine maternal baseline covariates and the number of multiple gestations; 385 patients with late moderate-to-critical OHSS were compared with a matched control group of 1,540 patients. The primary outcomes were the live birth rate, preterm delivery rate, miscarriage rate, gestational age at birth (weeks), obstetric complications and neonatal complications.

Results

The duration of gestation in the matched control group was significantly higher than that in the OHSS group. The live birth delivery rate did not significantly differ between the OHSS and matched control groups. The incidence rates of the obstetric complications venous thrombosis (VT) and gestational diabetes mellitus (GDM), neonatal complications and the number of neonates admitted to the NICU were significantly higher in the OHSS group than in the matched control group.

Conclusions

Pregnant women undergoing IVF with fresh ET whose course is complicated by late moderate-to-critical OHSS appear to experience shortened gestation and increased obstetrical and neonatal complications compared with matched controls whose course is not complicated by OHSS. However, the live birth rate, average neonatal weight, and incidence rates of premature delivery, miscarriage, early abortion, hypertensive disorder of pregnancy (HDP), placenta previa (PP), intrahepatic cholestasis of pregnancy (ICP), and low neonatal birth weight (LBW) did not differ significantly between the two groups.
Literature
1.
go back to reference Sutter PD, Gerris J, Dhont M. Assisted reproductive technologies: How to minimize the risks and complications in developing countries? 2008, 2008(1):73–76. Sutter PD, Gerris J, Dhont M. Assisted reproductive technologies: How to minimize the risks and complications in developing countries? 2008, 2008(1):73–76.
2.
go back to reference Toftager M, Bogstad J, Bryndorf T, Løssl K, Roskær J, Holland T, Prætorius L, Zedeler A, Nilas L, Pinborg A. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles. Hum Reprod. 2016;80(4):717. Toftager M, Bogstad J, Bryndorf T, Løssl K, Roskær J, Holland T, Prætorius L, Zedeler A, Nilas L, Pinborg A. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles. Hum Reprod. 2016;80(4):717.
3.
go back to reference Elchalal U, Schenker JG. The pathophysiology of ovarian hyperstimulation syndrome–views and ideas. Hum Reprod. 1997;12(6):1129.PubMedCrossRef Elchalal U, Schenker JG. The pathophysiology of ovarian hyperstimulation syndrome–views and ideas. Hum Reprod. 1997;12(6):1129.PubMedCrossRef
4.
go back to reference Committee JSOO, Shmorgun D, Claman P, Gysler M, Hemmings R, Cheung AP, Goodrow GJ, Hughes EG, Min JK, Roberts J. The diagnosis and management of ovarian hyperstimulation syndrome: No. 268, November 2011. Int J Gynaecol Obstet. 2012;116(3):268–73.CrossRef Committee JSOO, Shmorgun D, Claman P, Gysler M, Hemmings R, Cheung AP, Goodrow GJ, Hughes EG, Min JK, Roberts J. The diagnosis and management of ovarian hyperstimulation syndrome: No. 268, November 2011. Int J Gynaecol Obstet. 2012;116(3):268–73.CrossRef
5.
go back to reference Papanikolaou EG, Pozzobon C, Kolibianakis EM, Camus M, Tournaye H, Fatemi HM, Steirteghem AV, Devroey P. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril. 2006;85(1):112–20.PubMedCrossRef Papanikolaou EG, Pozzobon C, Kolibianakis EM, Camus M, Tournaye H, Fatemi HM, Steirteghem AV, Devroey P. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril. 2006;85(1):112–20.PubMedCrossRef
6.
go back to reference Rosalind B, Gabor K, Vivien ML, Caroline M, Baker HWG. Can you ever collect too many oocytes? Hum Reprod. 2015;30(1):81–7.CrossRef Rosalind B, Gabor K, Vivien ML, Caroline M, Baker HWG. Can you ever collect too many oocytes? Hum Reprod. 2015;30(1):81–7.CrossRef
7.
go back to reference Broer SL, Dólleman M, Opmeer BC, Fauser BC, Mol BW, Broekmans FJM. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Hum Reprod Update. 2011;17(1):46–54.PubMedCrossRef Broer SL, Dólleman M, Opmeer BC, Fauser BC, Mol BW, Broekmans FJM. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Hum Reprod Update. 2011;17(1):46–54.PubMedCrossRef
8.
go back to reference Raziel A, Schachter M, Friedler S, Ron-El R. Outcome of IVF pregnancies following severe OHSS. Reprod Biomed. 2009;19(1):61–5.CrossRef Raziel A, Schachter M, Friedler S, Ron-El R. Outcome of IVF pregnancies following severe OHSS. Reprod Biomed. 2009;19(1):61–5.CrossRef
9.
go back to reference Steward RG, Lan L, Shah AA, Yeh JS, Price TM, Goldfarb JM, Muasher SJ. Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles. Fertil Steril. 2014;101(4):967–73.PubMedCrossRef Steward RG, Lan L, Shah AA, Yeh JS, Price TM, Goldfarb JM, Muasher SJ. Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles. Fertil Steril. 2014;101(4):967–73.PubMedCrossRef
10.
go back to reference Vloeberghs V, Peeraer KA, D’Hooghe T. Ovarian hyperstimulation syndrome and complications of ART. Best Prat Res Cl Ob. 2009;23(5):691–709.CrossRef Vloeberghs V, Peeraer KA, D’Hooghe T. Ovarian hyperstimulation syndrome and complications of ART. Best Prat Res Cl Ob. 2009;23(5):691–709.CrossRef
11.
go back to reference Chen ZJ, Shi Y, Sun Y, Zhang B, Liang X, Cao Y, Yang J, Liu J, Wei D, Weng N. Fresh versus Frozen Embryos for Infertility in the Polycystic Ovary Syndrome. New Eng J Med. 2016;375(6):523.PubMedCrossRef Chen ZJ, Shi Y, Sun Y, Zhang B, Liang X, Cao Y, Yang J, Liu J, Wei D, Weng N. Fresh versus Frozen Embryos for Infertility in the Polycystic Ovary Syndrome. New Eng J Med. 2016;375(6):523.PubMedCrossRef
12.
go back to reference Blandine C, Virginie O, David B, Anne D, Agnès N, Marc G. Obstetric outcome of women with in vitro fertilization pregnancies hospitalized for ovarian hyperstimulation syndrome: a case-control study. Fertil Steril. 2011;95(5):1629–32.CrossRef Blandine C, Virginie O, David B, Anne D, Agnès N, Marc G. Obstetric outcome of women with in vitro fertilization pregnancies hospitalized for ovarian hyperstimulation syndrome: a case-control study. Fertil Steril. 2011;95(5):1629–32.CrossRef
13.
go back to reference Haas J, Yinon Y, Meridor K, Orvieto R. Pregnancy outcome in severe OHSS patients following ascitic/plerural fluid drainage. J Ovarian Res. 2014;7(1):56.PubMedPubMedCentralCrossRef Haas J, Yinon Y, Meridor K, Orvieto R. Pregnancy outcome in severe OHSS patients following ascitic/plerural fluid drainage. J Ovarian Res. 2014;7(1):56.PubMedPubMedCentralCrossRef
14.
go back to reference Jiang Xuan, Deng Cheng-Yan, Sun Zheng-Yi, Chen Wei-Lin, Wang Han-Bi, Zhou Yuan-Zheng, Jin Li. Pregnancy Outcomes of In Vitro Fertilization with or without Ovarian Hyperstimulation Syndrome: A Retrospective Cohort Study in Chinese Patients. J Chinese Med. 2015;128(23):3167–72.CrossRef Jiang Xuan, Deng Cheng-Yan, Sun Zheng-Yi, Chen Wei-Lin, Wang Han-Bi, Zhou Yuan-Zheng, Jin Li. Pregnancy Outcomes of In Vitro Fertilization with or without Ovarian Hyperstimulation Syndrome: A Retrospective Cohort Study in Chinese Patients. J Chinese Med. 2015;128(23):3167–72.CrossRef
15.
go back to reference Luke B, Brown MB, Morbeck DE, Hudson SB, Rd CC, Stern JE. Factors associated with ovarian hyperstimulation syndrome (OHSS) and its effect on assisted reproductive technology (ART) treatment and outcome. Fertil Steril. 2010;94(4):1399–404.PubMedCrossRef Luke B, Brown MB, Morbeck DE, Hudson SB, Rd CC, Stern JE. Factors associated with ovarian hyperstimulation syndrome (OHSS) and its effect on assisted reproductive technology (ART) treatment and outcome. Fertil Steril. 2010;94(4):1399–404.PubMedCrossRef
16.
go back to reference Papanikolaou EG, Herman T, Willem V, Michel C, Valérie V, Andre VS, Paul D. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile. Hum Reprod. 2005;20(3):636–41.PubMedCrossRef Papanikolaou EG, Herman T, Willem V, Michel C, Valérie V, Andre VS, Paul D. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile. Hum Reprod. 2005;20(3):636–41.PubMedCrossRef
17.
go back to reference Wiser A, Levron J, Kreizer D, Achiron R, Shrim A, Schiff E, Dor J, Shulman A. Outcome of pregnancies complicated by severe ovarian hyperstimulation syndrome (OHSS): a follow-up beyond the second trimester. Hum Reprod. 2005;20(4):910–4.PubMedCrossRef Wiser A, Levron J, Kreizer D, Achiron R, Shrim A, Schiff E, Dor J, Shulman A. Outcome of pregnancies complicated by severe ovarian hyperstimulation syndrome (OHSS): a follow-up beyond the second trimester. Hum Reprod. 2005;20(4):910–4.PubMedCrossRef
18.
go back to reference Arieh R, Shevach F, Morey S, Deborah S, Eitan M, Raphael RE. Increased early pregnancy loss in IVF patients with severe ovarian hyperstimulation syndrome. Hum Reprod. 2002;17(1):107–10.CrossRef Arieh R, Shevach F, Morey S, Deborah S, Eitan M, Raphael RE. Increased early pregnancy loss in IVF patients with severe ovarian hyperstimulation syndrome. Hum Reprod. 2002;17(1):107–10.CrossRef
19.
go back to reference Practice Committee of the American Society for Reproductive Medicine. 2016. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Steril. 2016, 1634–1647. Practice Committee of the American Society for Reproductive Medicine. 2016. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Steril. 2016, 1634–1647.
20.
go back to reference Austin PC. An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies. Multivariate Behav Res. 2011;46(3):399–424.PubMedPubMedCentralCrossRef Austin PC. An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies. Multivariate Behav Res. 2011;46(3):399–424.PubMedPubMedCentralCrossRef
21.
go back to reference Axelsson KF, Nilsson AG, Wedel H, Lundh D, Lorentzon M. Association Between Alendronate Use and Hip Fracture Risk in Older Patients Using Oral Prednisolone. Jama. 2017;318(2):146–55.PubMedPubMedCentralCrossRef Axelsson KF, Nilsson AG, Wedel H, Lundh D, Lorentzon M. Association Between Alendronate Use and Hip Fracture Risk in Older Patients Using Oral Prednisolone. Jama. 2017;318(2):146–55.PubMedPubMedCentralCrossRef
22.
go back to reference Guillaume D, Jean-Fran Ois H, Pierre-Emmanuel B, Guillaume L, Laurent V, Loic S. Maternal and Neonatal Morbidity After Attempted Operative Vaginal Delivery According to Fetal Head Station. Obstetrics Gynecology. 2015;126(3):521–9.CrossRef Guillaume D, Jean-Fran Ois H, Pierre-Emmanuel B, Guillaume L, Laurent V, Loic S. Maternal and Neonatal Morbidity After Attempted Operative Vaginal Delivery According to Fetal Head Station. Obstetrics Gynecology. 2015;126(3):521–9.CrossRef
23.
go back to reference Ensing S, Abu-Hanna A, Roseboom TJ, Repping S, Veen FVD, Mol BWJ, Ravelli ACJ. Risk of poor neonatal outcome at term after medically assisted reproduction: a propensity score-matched study. Fertil Steril. 2015;104(2):384–90.PubMedCrossRef Ensing S, Abu-Hanna A, Roseboom TJ, Repping S, Veen FVD, Mol BWJ, Ravelli ACJ. Risk of poor neonatal outcome at term after medically assisted reproduction: a propensity score-matched study. Fertil Steril. 2015;104(2):384–90.PubMedCrossRef
24.
go back to reference Luo Z, Gardiner JC, Bradley CJ. Applying propensity score methods in medical research: pitfalls and prospects. Medical Care Research Review Mcrr. 2010;67(5):528.PubMedCrossRef Luo Z, Gardiner JC, Bradley CJ. Applying propensity score methods in medical research: pitfalls and prospects. Medical Care Research Review Mcrr. 2010;67(5):528.PubMedCrossRef
25.
go back to reference Uppal S, Bazzi A, Reynolds RK, Harris J, Pearlman MD, Campbell DA, Morgan DM. Chlorhexidine-Alcohol Compared With Povidone-Iodine for Preoperative Topical Antisepsis for Abdominal Hysterectomy. Obstet Gynecol. 2017;130(2):1.CrossRef Uppal S, Bazzi A, Reynolds RK, Harris J, Pearlman MD, Campbell DA, Morgan DM. Chlorhexidine-Alcohol Compared With Povidone-Iodine for Preoperative Topical Antisepsis for Abdominal Hysterectomy. Obstet Gynecol. 2017;130(2):1.CrossRef
26.
go back to reference Csokmay JM, Yauger BJ, Henne MB, Armstrong AY, Queenan JT, Segars JH. Cost Analysis Model of Outpatient Management of OHSS with Paracentesis: ‘Tap Early and Often’ Versus Hospitalization. Fertil Steril. 2010;93(1):167–73.PubMedCrossRef Csokmay JM, Yauger BJ, Henne MB, Armstrong AY, Queenan JT, Segars JH. Cost Analysis Model of Outpatient Management of OHSS with Paracentesis: ‘Tap Early and Often’ Versus Hospitalization. Fertil Steril. 2010;93(1):167–73.PubMedCrossRef
27.
go back to reference Martin AS, Monsour M, Kissin DM, Jamieson DJ, Callaghan WM, Boulet SL. Trends in Severe Maternal Morbidity After Assisted Reproductive Technology in the United States, 2008–2012. Obstet Gynecol. 2016;127(1):59–66.PubMedCrossRef Martin AS, Monsour M, Kissin DM, Jamieson DJ, Callaghan WM, Boulet SL. Trends in Severe Maternal Morbidity After Assisted Reproductive Technology in the United States, 2008–2012. Obstet Gynecol. 2016;127(1):59–66.PubMedCrossRef
28.
go back to reference Haas J, Baum M, Meridor K, Hershko-Klement A, Elizur Shai, Hourvitz A, Orvieto R, Yinon Y. Is severe OHSS associated with adverse pregnancy outcomes? Evidence from a case–control study. Reprod. Biomed. Online. 2014;29(2):216–21.PubMedCrossRef Haas J, Baum M, Meridor K, Hershko-Klement A, Elizur Shai, Hourvitz A, Orvieto R, Yinon Y. Is severe OHSS associated with adverse pregnancy outcomes? Evidence from a case–control study. Reprod. Biomed. Online. 2014;29(2):216–21.PubMedCrossRef
Metadata
Title
Patients with IVF complicated by moderate-to-critical OHSS experience increased thrombosis, GDM and neonatal NICU admission but slightly shorter gestation compared with matched IVF counterparts: A retrospective Chinese cohort study
Authors
Linli Hu
Rui Xie
Mengying Wang
Yingpu Sun
Publication date
01-12-2021

Other articles of this Issue 1/2021

Reproductive Biology and Endocrinology 1/2021 Go to the issue